香港股市 已收市

Immunocore Holdings plc (IMCR)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
65.00+1.42 (+2.23%)
收市:04:00PM EDT
62.22 -2.78 (-4.28%)
收市後: 05:01PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價63.58
開市63.50
買盤64.62 x 200
賣出價65.09 x 300
今日波幅63.13 - 65.26
52 週波幅42.21 - 76.98
成交量356,003
平均成交量491,452
市值3.238B
Beta 值 (5 年,每月)0.91
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-1.43
業績公佈日2024年5月08日 - 2024年5月12日
遠期股息及收益率無 (無)
除息日
1 年預測目標價85.58
  • InvestorPlace

    Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio

    Since Bill Gates left his position with Microsoft (NASDAQ:MSFT) he diversified his stock portfolio away from the tech giant. Instead, biotechnology has been is primary interest. Gates was one of the loudest voices during the Covid-19 pandemic for providing therapeutics to poor countries and elsewhere. His Bill and Melinda Gates Foundation used its clout to influence response to the disease by governments around the world. The Foundation also gave more than $1 billion to the World Health Organiza

  • Insider Monkey

    Immunocore Holdings plc (NASDAQ:IMCR) Q4 2023 Earnings Call Transcript

    Immunocore Holdings plc (NASDAQ:IMCR) Q4 2023 Earnings Call Transcript February 28, 2024 Immunocore Holdings plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the Immunocore Fourth Quarter Financial Results Conference Call. At this time, all participants are […]

  • Zacks

    Sarepta's (SRPT) DMD Drug sBLA Gets FDA's Priority Tag, Stock Up

    Sarepta (SRPT) announces the FDA's acceptance of its efficacy supplement to the Elevidys BLA, seeking to expand the treatment label for its DMD drug. The stock gains 8%.